Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Continued Safety and Performance of the TIVUS System
Phase 2
- Conditions
- Hypertension, Resistant to Conventional Therapy
- First Posted Date
- 2013-04-19
- Last Posted Date
- 2014-03-26
- Lead Sponsor
- Cardiosonic
- Target Recruit Count
- 80
- Registration Number
- NCT01835535
- Locations
- 🇦🇺
Royal Perth Hospital, Perth, Australia
News
No news found